Abstract
> FDG—the molecule of the (last) century. PSMA—the target of this and the next decade. > > —Richard P. Baum, fourth Theranostics World Congress (2016), Melbourne, Australia Every year, a myriad of promising new radiopharmaceuticals is described in The Journal of Nuclear Medicine, but few
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
